Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in RGC — Regencell Bioscience Holdings Ltd

CIK 1214717 BOSTON, MA

Position in RGC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,570,046
-$7,997,873 QoQ
Shares Held
422,011
+1.6% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 35 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RGC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. RGC ranks #38 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGC

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,570,046 422,011
2026-03-31 $10,567,919 415,569
2025-12-31 $8,674,722 413,082
2025-09-30 $6,488,536 419,970
2025-06-30 $6,663,764 391,066
2025-03-31 $217,281 6,816
2022-09-30 $216,737 6,816
2022-06-30 $235,878 6,816
2021-12-31 $217,100 6,816